patience wildenfels, md - amazon web services · 2019-07-20 · frequent voiding with low pressure...
TRANSCRIPT
Patience Wildenfels, MD
Division of Pediatric Urology
Ochsner Health System
July 20, 2019
GUIDELINE STATEMENTS
Evaluation and Treatment of Cryptorchidism
(AUA Guidelines published 2014)
Guideline Key Points▪ Cryptorchidism or undescended testis (UDT) is one of the most common
pediatric disorders
▪ 1% - 4% of full-term and 1% -45% of preterm newborn
▪ The main reasons for treatment of cryptorchidism
▪ Increased risks of impairment of fertility potential
▪ Testicular malignancy
▪ Testicular torsion
▪ +/- associated inguinal hernia
▪ Successful scrotal relocation of the testis, however, may reduce but
does not prevent these potential long-term sequelae in susceptible
individuals.
Guideline Key Points
▪ Cryptorchidism, or undescended testis (UDT), is defined as failure of a testis
to descend into a scrotal position.
▪ Normal scrotal position has been defined as positioning of the midpoint of
the testis at or below the midscrotum (Dependent portion of scrotum)
Guideline Key Points
▪ Although “high scrotal testes” are not routinely considered
undescended by most clinicians, they are included in the definition of
UDT in some epidemiologic studies.
▪ Because…. Some of these are ok & stable- however some are not!
▪ Stable descended testes that reside above the scrotal midpoint
▪ Retractile
▪ Undescended “gliding” testes , which are Not stable
GUIDELINE STATEMENTS
▪ Guideline Statement 1
▪ Providers should obtain gestational history at initial evaluation of
boys with suspected cryptorchidism.
▪ (Standard; Evidence Strength: Grade B)
▪ Guideline Statement 2
▪ Primary care providers should palpate testes for quality and position
at each recommended well-child visit.
▪ (Standard; Evidence Strength: Grade B)
Guideline Statement 3
▪ Providers should refer infants with a history of
cryptorchidism (detected at birth) who do not have
spontaneous testicular descent by six months (corrected
for gestational age) to an appropriate surgical specialist
for timely evaluation.
▪ (Standard; Evidence Strength: Grade B)
Guideline Statement 4
▪ Providers should refer boys with the possibility of newly
diagnosed (Acquired) cryptorchidism after six months
(corrected for gestational age) to an appropriate surgical
specialist.
▪ (Standard; Evidence Strength: Grade B)
Guideline Statement 5
▪ Providers must immediately consult an appropriate specialist for
all phenotypic male newborns with bilateral, nonpalpable testes
for evaluation of a possible disorder of sex development (DSD).
▪ (Standard; Evidence Strength: Grade A)
Guideline Statement 8
▪ In boys with bilateral, nonpalpable testes who do not have
congenital adrenal hyperplasia (CAH),
▪ providers should measure Müllerian Inhibiting Substance (MIS)
or Anti- Müllerian Hormone [AMH] and consider additional
hormone testing to evaluate for anorchia.
▪ (Option; Evidence Strength: Grade C)
Guideline Statement 7
▪ Providers should assess the possibility of a Disorder of Sex
Development (DSD) when there is increasing severity of
hypospadias with cryptorchidism.
▪ (Recommendation; Evidence Strength: Grade C)
Guideline Statement 6
▪ Providers should not perform ultrasound (US) or other
imaging modalities in the evaluation of boys with
cryptorchidism prior to referral, as these studies rarely
assist in decision making.
▪ (Standard; Evidence Strength: Grade B)
Guideline Statement 9
▪ In boys with retractile testes, providers should assess the
position of the testes at least annually to monitor for
secondary ascent.
▪ (Standard; Evidence Strength: Grade B)
RETRACTILE TESTES
▪ - initially extrascrotal on examination or moves easily out
of scrotal position, but can be manually replaced in
stable, dependent scrotal position and remain there
without tension at least temporarily.
▪ often associated with a vigorous cremasteric reflex
GUIDELINE STATEMENT 10
▪ Providers should not use hormonal therapy to induce
testicular descent as evidence shows low response rates
and lack of evidence for long-term efficacy.
▪ (Standard; Evidence Strength: Grade B)
Guideline Statement 11- Surgery
▪ In the absence of spontaneous testicular descent by six
months (corrected for gestational age), specialists should
perform surgery within the next year.
▪ (Standard; Evidence Strength: Grade B)
Guideline Statement 16
▪ Providers should counsel boys with a history of
cryptorchidism and/or monorchidism and their parents
regarding potential long-term risks and provide education
on infertility and cancer risk.
▪ (Clinical Principle)
Posterior Urethral Valves
Still here and living longer
Posterior Urethral Valves
Anatomy 101
“Bladder Neck”
“Bladder Outlet”
“Verumontanum”
(seminal colliculus)
“Perineal Membrane”
What is the posterior urethra anyway?
▪ Urethra
▪ two broad segments: the anterior urethra and
posterior urethra
▪ posterior urethra
begins distal to the
bladder neck & runs
to the perineal
membrane
▪ anterior urethra
begins at the
perineal membrane
& continues distally
to urethral meatus
PUV is a
Congenital
Obstruction of
Bladder Outlet
(within the posterior
urethra)
ANTEGRADE problem!
Posterior Urethral Valves
Is most common cause of bladder outlet obstruction in
infants: presentation is often antenatal, and
pathognomonic findings on post natal images typically
confirm diagnosis
Few problems like this in a newborn male: ironic actually
Its easy to detect, easy for initial treatment with valve
ablation but not easy! life long problems
PUV- EPIDEMIOLOGY▪ Congenital Anomalies of the Urinary Tract affect of 1 in 500 pregnancies and
obstructive type issues are the most common (UPJ, PUV, etc)
▪ The incidence (risk of having PUV) is between 1.6 and 2.1 per 10,000 births.
▪ The prevalence (proportion of PUV in the population at any given time) is
2.10 per 10,000 births.
▪ Consider this …
▪ In USA alone - expect 300 to 500 new cases of infants with PUV born
annually—of which 1/3 will go on to End-Stage Renal Failure(ESRF)
▪ COST of THIS IS GINORMOUS!
▪ Abortions, still births, access to care…
Classification of PUV types
▪ 1st proposed in 1919
▪ 3 Types
▪ TYPE 1- most common 90-95% cases
▪ “LEAFLETS” that out pouch with voiding and obstruct
▪ Type 2- Unicorns
▪ Type 3- 5-10 % cases
▪ Annular ring with small hole in center
TYPE 1 PUV- 90-95% casesTYPE 1 variant “leaflets” that arise from the verumontanum and fuse in
the midline just proximal to the external urethral sphincter.
TYPE 2 – Unicorns
TYPE 3
concentric ring with central opening (5-10%)
Antegrade voiding
DIAGNOSTIC TOOLS
Fetal MRI
Ultrasound
VCUG
LABS
Renal Scan
Bilateral severe
pelvicaliectasis & bladder
Keyhole sign, thickened
bladder
Fetal MRI
Being used more mostly at major centers- utility is limited
High Alert
▪ Do NOT let this baby go home without
workup!
▪ Needs renal u/s and when stable VCUG
BEFORE discharge
Pathognomonic VCUG
Voiding phase will show contrast
traveling across a hypertrophied,
elevated bladder neck and grossly
dilated posterior urethra
The urethra funnels abruptly at a
transverse membrane, or “leaflets”
Clinical Presentation
▪ Neonatal
▪ Early Infancy
▪ Dribbling / poor urinary stream
▪ Urosepsis
▪ Dehydration
▪ Electrolyte abnormalities
▪ Uremia
▪ Failure to thrive; (renal insufficiency)
Clinical presentation
▪ Toddlers
▪ Better renal function (less obstruction)
▪ Febrile UTI
▪ Voiding dysfunction – incontinence
▪ Daytime incontinence may be the only symptom in boys
with less severe obstruction
Pathophysiology
Why are PUV bad?
Clinical Comorbidities
PULMONARY HYPOPLASIA
Most profound complication & Most common cause of perinatal mortality in infants affected
by severe LUTO
Lifelong potential for issues
Pulmonary abnormalities start BEFORE oligohydramnios
Pathophysiology
▪ Despite early cystoscopy and valve ablation
there are a lifetime of consequences from
the in utero obstruction
▪ Bladder dysfunction
▪ Renal dysplasia
▪ Polyuria
▪ Worsening bladder dysfunction….
▪ ESRD/Transplant
Bladder Problems in PUV
Major Importance:
The potential comorbidities arising from PUV—
renal dysfunction, urine reflux, worsening
hydronephrosis—are due to bladder
dysfunction
Compliance- bladder has to be able to store
urine at low pressure and has to be able to
empty urine sufficiently
Bladder dysfunction- “Valve Bladder”
Pathophysiologic cascade of changes due to early
exposure to obstruction, cascade continues…
Voiding dysfunction
Urinary reflux
Worsening of renal dysplasia
All conspire to manifest as the dysfunction of :
VALVE BLADDER SYNDROME
Valve Bladder Syndrome
Throughout childhood the bladder progresses through 3
distinct contractility cycles
1. Detrusor hyperreflexia in infancy-early childhood (over active
bladder)
2. Decreasing intravesical pressures and improved compliance of
bladder in childhood
3. Increased bladder capacity with hypocontractility and atony in
adulthood (maybe adolescence) (BIG FLOPPY BAD BLADDERS)
Valve Bladder Dysfunction/Syndrome
▪ Must always suspect valve bladder even when not
suspected by history alone!
▪ Looking for INCONTINENCE- VOIDING PROBLEMS-FREQUENCY….
▪ Reliance on clinical examination or patient questionnaires alone may grossly
underestimate bladder dysfunction
Vesicoureteral Reflux and Dysplasia
(VURD)
▪ VURD
▪ The hypothesis: reflux served as a “pop-off” mechanism in which the
dysplastic kidney with reflux served as a pressure reservoir mitigating
damage to the contralateral kidney, and coined the term
vesicoureteral reflux and dysplasia
▪ This appears to be a short-term protective mechanism
▪ Cuckow et al found that, whereas 67% of patients affected by VURD
during year 2 of life had a normal serum creatinine, only 30% of these
children had normal values between ages 8 and 10 years
Valve Bladder- Follow up
▪ Obtaining a uroflow and checking postvoid residuals should be a routine part
of follow-up in toilet-trained children with a history of posterior urethral
valves
▪ Upper tract assessment with renal ultrasonography
▪ Renal function panel (GFR critical to follow)
We are a team: observation, clinical history,
imaging, labs, and urodynamics
Valve Bladder Dysfunction/Syndrome
POTTY TRAINING
▪ Counsel Parents: Do Not aggressively push an affected child toward toilet training & expect a lag compared to the normal population.
▪ Daytime incontinence is not uncommon, ranging from 7% to 35%
▪ Nocturnal enuresis is expected in 1 of 4 children with a hx of PUV
▪ Once toilet training is achieved, children and caregivers are educated to ensure adequate fluid intake, to void on a timed regimen, and to practice double voiding.
▪ Biofeedback therapy and home pelvic floor exercises have also been shown to be useful
PUV Bladder- medical management
▪ Plan should be from Pediatric Urologist
▪ Frequent voiding with low pressure
▪ Timed and double voids
▪ (extended release preferred but is pill)
▪ Alpha-blocker (pills)
▪ Monitor Post Void Residuals!!
▪ Uroflow/urodynamic testing
▪ CIC- clean intermittent catheterization- for bladder myogenic failure
▪ Overnight Bladder Catheter for at risk patients with renal dysfunction
Catheterization
▪ CIC
▪ The utilization of CIC can be challenging in PUV patients due to the sensate urethra
and bladder neck hypertrophy
▪ IF You Don’t Need, and do it- no change
▪ BUT if You NEED it, and Don’t do it, progression of renal failure
Medical Management
just to stress…
❖ Given the increased risk of ESRD, critical to follow glomerular filtration rate
(GFR)
❖ Adolescents need follow up too! - metabolic demand of the associated
growth spurt and decreased renal reserve
❖ Delayed myogenic/detrusor failure due to “valve bladder cycle” should
always be investigated when urologic testing reveals increased PVR or
worsening upper tract dilation.
Prognostic Indicators for Renal Function
▪ Lifetime prevalence of end-stage renal disease in boys
with posterior urethral valves is between 20% and 50%
▪ Age at diagnosis
▪ Renal dysplasia with or without vesicoureteral reflux
▪ Nadir creatinine during 1 year of life,
▪ Recurrent urinary tract infections,
▪ Bladder dysfunction.
Nadir Creatinine
▪ A serum creatinine of less than 0.8 mg/dL appears to
indicate a minimal risk, whereas a value greater than
1.2 mg/dL at 1 year of age predicts a higher risk of
developing end-stage renal failure
▪ The nadir creatinine value measured at 1 year of life appears to be more
accurate as a predictive tool than the value obtained at 1 month of age
▪ In those studies suggesting that a 1-month post-treatment serum creatinine is
a more accurate predictor of renal function, again the value of less than
0.8 mg/dL at 1 month after treatment seems to indicate better long-term
outcomes
Risk
▪ In McLeod(2019) series by 10 years of follow-up
▪ a nadir serum creatinine <0.4 mg/dL was associated with 0% risk of
RRT whereas 100% of patients with a nadir serum creatinine >1.0
mg/dL experienced outcome of requiring Renal Replacement
Therapy
▪ Additional ranges showed intermediate risk illustrating the variable
renal outcomes of the PUV patient and need for extended follow up
Transplant
▪ The prevalence of end-stage renal disease in boys with a history of
posterior urethral valves is up to 50%
▪ At any given time- 50% of the boys with PUV have ESRD!
▪ 2006 annual report of the North American Pediatric Renal Trials and
Collaborative Studies listed obstructive uropathy as the second most
common cause for transplantation, accounting for 1424 of 8990
transplantation cases (15.8%) since 1987
Transplant
▪ Transplant recipients in whom bladder dysfunction is incompletely managed
or the bladder reservoir is not optimized have significantly higher
complication rates and graft loss rates
Transplant
▪ Pediatric Urologist should be critical part of team
▪ Video urodynamics
▪ Determine safe bladder pressures
▪ Contractile function
▪ Determine proper bladder management skills
▪ CIC
▪ Overnight catheter drainage
▪ Good skills critical for graft survival
MOST IMPORTANTLY…
We are nice people!
We Want to Help You!
We are a phone call or text or email or
anything away 24/7!
PLEASE CALL ANYTIME
Patience Wildenfels, MD
504-343-0380 cell
(NOLA, BR, Covington)
Frank Cerniglia, MD
504-417-1540 cell
(NOLA, Slidell)
PEDI URO Office/Clinic- DIRECT
504-703-0809
504-703-0808
504-842-4083- main urology